Announcements Trials
Browse Landscape

Status

Completed 164Recruiting 47Terminated 37Active not recruiting 31Unknown 17Not yet recruiting 8Withdrawn 6Approved for marketing 4Enrolling by invitation 2Suspended 1No longer available 1Available 1

Sponsor Class

OTHER 15OTHER_GOV 2INDUSTRY 2NIH 1

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 15Genitourinary 13Thoracic 9Other hematologic neoplasm 9Other solid neoplasm 8Lymphoid 8Breast 8CNS 7Gynecologic 6Tumor-Agnostic 4Plasma cell 3Sarcoma 2Myeloid 2Head & Neck 2Endocrine 2Dermatologic 2NET 1

Conditions

Neuroendocrine Tumors 1Neoplasms 1Dwarfism, Pituitary 1Disease Progression 1Diabetes Mellitus, Type 2 1Carcinoma, Neuroendocrine 1Carcinoid Tumor 1

Interventions

somapacitan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × INDUSTRY × Endocrine × Clear all
NCT06709040 2026-04-06

A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters

Novo Nordisk A/S

Enrolling by invitation
500 enrolled
Endocrine

Diabetes Mellitus, Type 2, Dwarfism, Pituitary, Neoplasms

NCT02270567 2025-11-13

RegisterNET

Wren Laboratories LLC

Enrolling by invitation
400 enrolled
EndocrineNET

Carcinoid Tumor, Carcinoma, Neuroendocrine, Neuroendocrine Tumors, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡